BioNTech

Dr Robert Hess: A first step in the right direction

Dr Robert Hess: A first step in the right direction: BioNTech introduces the “individualization” concept into vaccination strategy. Where are we now, almost two years into the pandemic? Nine months after the first vaccines for the prevention of Covid-19 were approved, are there any conclusions that can be reliably drawn? Since December 2020, 2.39 billion…

Read More

Dr Robert Hess: FDA grants full approval to the Pfizer

Dr Robert Hess: FDA grants full approval to the Pfizer/BioNTech COVID-19 vaccine – What exactly does full FDA approval of a vaccine mean? The Pfizer/BioNTech COVID-19 vaccine first received Emergency Use Authorization (EUA) from the U.S. authorities in mid-December 2020 for administration to persons aged 16 and older. On Monday, the FDA announced that it…

Read More

Dr Robert Hess: Any decision on whether to receive a booster jab

Dr Robert Hess: Any decision on whether to receive a booster jab (and which one to choose) or to wait for a next-generation vaccine should be based on the following criteria. 1 – Which is preferable – a booster jab or a next-generation vaccine? This depends on a number of factors, primarily which next-generation vaccine…

Read More

As Dr Robert Hess expected, the pandemic is becoming more complex

As Dr Robert Hess expected, the pandemic is becoming more complex and problematic in nature, which makes it all the more difficult to make any firm predictions for the autumn. In focus: Vaccine side-effects versus post-acute sequelae (“Long Covid”). The forecast of Dr Robert Hess in the spring of 2021 that the pandemic would take…

Read More

Differing opinions about the Lambda variant

Differing opinions about the Lambda variant: Super mutant, successor to Delta or damp squib? For the first time since the SARS-CoV-2 Task Force was established 18 months ago, a difference of opinion has arisen, specifically with regard to the Lambda variant. What everyone agrees on is that the Lambda or C.37 variant is clearly more…

Read More

The skepticism of Dr Robert Hess regarding the efficacy of all previous vaccines against the Delta variant has been confirmed

The skepticism of Dr Robert Hess regarding the efficacy of all previous vaccines against the Delta variant has been confirmed by the announcement from BioNTech/Pfizer that they are working on a vaccine that will specifically target this mutant. The Delta variant of the novel coronavirus, which is causing concern across the whole of Europe, is…

Read More

CureVac were our great hope

CureVac was the great hope of Dr Robert Hess. They reached for the stars – and came back down with a bump. Though the news was not entirely unexpected, we regret to report that the breakthrough vaccine promised by CureVac will now not be forthcoming. There are a number of reasons for this, but the…

Read More